Cargando…
Impediments to Enhancement of CPT-11 Anticancer Activity by E. coli Directed Beta-Glucuronidase Therapy
CPT-11 is a camptothecin analog used for the clinical treatment of colorectal adenocarcinoma. CPT-11 is converted into the therapeutic anti-cancer agent SN-38 by liver enzymes and can be further metabolized to a non-toxic glucuronide SN-38G, resulting in low SN-38 but high SN-38G concentrations in t...
Autores principales: | Hsieh, Yuan-Ting, Chen, Kai-Chuan, Cheng, Chiu-Min, Cheng, Tian-Lu, Tao, Mi-Hua, Roffler, Steve R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331512/ https://www.ncbi.nlm.nih.gov/pubmed/25688562 http://dx.doi.org/10.1371/journal.pone.0118028 |
Ejemplares similares
-
Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity
por: Hsieh, Yuan-Ting, et al.
Publicado: (2015) -
Discovery of Specific Inhibitors for Intestinal E. coli
β-Glucuronidase through In Silico Virtual Screening
por: Cheng, Ta-Chun, et al.
Publicado: (2015) -
Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity
por: Lin, Hsien-Ya, et al.
Publicado: (2021) -
The effect of therapeutic radiation on serum and urine beta-glucuronidase.
por: Watts, C., et al.
Publicado: (1966) -
Lumenal location of the microsomal beta-glucuronidase-egasyn complex
Publicado: (1987)